Atlas Trials

Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment

Clinical trial NCT05132790 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05132790
Sponsor
Shengjing Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-09-25
Primary completion
2024-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.